使用瓦雷尼克林与电子尼古丁递送系统 (ENDS) 结合使用
Jed E Rose1, Frederique M Behm1, Perry N Willette1
1Rose Research Center, LLC, 7240 ACC Blvd, Raleigh, NC 27617, USA.
瓦伦尼克林与电子尼古丁输送系统 (ENDS) 相结合,显著减少了吸烟和依赖. 这种组合有望帮助吸烟者转向ENDS,提供长期的行为替代品.
科学领域:
- 尼古丁成研究 尼古丁成研究
- 用于戒烟的药理疗法
- 行为科学是一种行为科学.
背景情况:
- 瓦伦尼克林在戒烟方面是有效的,但复发很常见.
- 电子尼古丁输送系统 (ENDS) 可能作为吸烟的行为替代品.
- 将尼古丁依赖转移到ENDS可以阻止长期吸烟.
研究的目的:
- 为了评估瓦雷尼克林与ENDS一起使用.
- 为了促进从香烟转向ENDS.
- 评估这种组合对减少吸烟的有效性.
主要方法:
- 25名有兴趣更换烟草的吸烟者参与了这项研究.
- 参与者接受了13周的ENDS,并在第2-13周接受了瓦雷尼克林.
- 评估包括自我报告的使用,一氧化碳水平,奖励等级和依赖度.
主要成果:
- 吸烟量从每天15.6支降至每天2.8支.
- 28%的参与者在最后4周内实现了确认的戒断.
- 使用ENDS和瓦里尼克林,香烟依赖程度显著下降;使用ENDS的依赖程度增加.
结论:
- 将ENDS与瓦雷尼克林结合使用显示了减少吸烟依赖的潜力.
- 这种组合可能有助于从香烟转向ENDS.
- 这种方法似乎是可以容忍的,并且遵守率很高.
更多相关视频
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
相关概念视频
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Inhaled Medications
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
